Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / Common Shares, no par value
-
Shares outstanding
-
33,289,095
-
Number of holders
-
48
-
Total 13F shares, excl. options
-
3,360,539
-
Shares change
-
-625,921
-
Total reported value, excl. options
-
$18,915,124
-
Value change
-
-$4,739,956
-
Number of buys
-
28
-
Number of sells
-
-33
-
Price
-
$5.63
Significant Holders of XBiotech Inc. - Common Shares, no par value (XBIT) as of Q2 2022
67 filings reported holding XBIT - XBiotech Inc. - Common Shares, no par value as of Q2 2022.
XBiotech Inc. - Common Shares, no par value (XBIT) has 48 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 3,360,539 shares
of 33,289,095 outstanding shares and own 10.1% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (854,293 shares), MILLENNIUM MANAGEMENT LLC (284,679 shares), BlackRock Inc. (254,932 shares), CREDIT SUISSE AG/ (226,139 shares), MORGAN STANLEY (201,722 shares), DIMENSIONAL FUND ADVISORS LP (167,095 shares), GEODE CAPITAL MANAGEMENT, LLC (151,396 shares), Oasis Management Co Ltd. (137,174 shares), CITADEL ADVISORS LLC (80,884 shares), and RENAISSANCE TECHNOLOGIES LLC (78,668 shares).
This table shows the top 48 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.